Researchers conducted laboratory-and population-based surveillance in certain areas in Colorado, Georgia, Maryland, Minnesota, New Mexico, New York, Oregon and Tennessee. They collected carbapenem-nonsusceptible A. baumannii cultured from urine or normally sterile sites. They identified 621 cases in 537 patients.
The crude annual incidence was 1.2 cases per 100,000 persons. Among the 598 cases for which complete data were available, 98.7 percent occurred among patients with overnight stays in a hospital during the previous year. Around 84.6 percent occurred in patients who had an indwelling device.
“Although incidence was lower than for other healthcare-associated pathogens, cases were associated with substantial rates of illness and death,” study authors concluded.
More articles on healthcare quality:
House rejects ‘right-to-try’ bill: 9 things to know
National Institute on Drug Abuse recognizes NYU Langone Health’s Dr. Nathaniel Landau
ECRI Institute ranks 10 top patient safety concerns for 2018
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.